Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445064-16-000233
Filing Date
2016-03-18
Accepted
2016-03-18 17:01:50
Documents
1
Period of Report
2016-03-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4751
  Complete submission text file 0001445064-16-000233.txt   6065
Mailing Address C/O GAP, INC. 2 FOLSOM ST. SAN FRANCISCO CA 94105
Business Address
YOUNGBLOOD DR KNEELAND (Reporting) CIK: 0001137820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 161516751

Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations